NIH Quietly Adds Ivermectin to COVID-19 Treatment Guidelines as Antiviral Therapy
The National Institutes of Health (NIH) has quietly added ivermectin to their list of antiviral therapies for their COVID-19 treatment guidelines.
“Ivermectin is an antiparasitic drug that is being evaluated to treat COVID-19,” the NIH states on their website, although they note that “ivermectin is not approved by the FDA for the treatment of any viral infection.”
The NIH guidelines promoting ivermectin can be seen here:
Suddenly Ivermectin shows up on the NIH website for treating Covid. After years of denial, blocking, interference, villification, ruining social media accounts, killing people, etc. they silently add it to their antiviral protocol. pic.twitter.com/iSDwYLlU1O
— Dusty Desert Dweller (@dusty_dweller) August 31, 2022
The NIH is promoting ivermectin after an aggressive demonization campaign from the public health establishment was waged to keep it out of the hands of suffering COVID-19 patients during the heart of the pandemic.
Big League Politics reported on how patients were denied ivermectin by health care providers as COVID-19 turned medical professionals into the murderous enforcers of Big Pharma’s profit margins:
“An Ohio judge ordered a hospital to treat a man with ivermectin as he’s gravely sick with coronavirus disease, potentially opening the door for patients who wish to try the experimental treatment against the will of healthcare providers.
Jeffrey Smith will receive ivermectin following an emergency lawsuit on the part of his wife, Julie. Julie Smith had consulted on the possibility of treating Mr. Smith with Dr. Fred Wagshul.